Over the last decade, MSI1 has emerged as an oncogenic protein that functions as a stem cell determinant to promote cancer cell survival, tumor progression, and its expression is closely correlated to drug resistance and cancer relapse in patients [33,34]. This evidence concerns the gene MSI1 and cancer.